Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01275742 · ClinicalTrials.gov registry record · NA

Helping Others Toward Positive Emotions in People With Heart Failure

A NA study of Heart Failure, sponsored by Rebecca L. Dekker, PhD, RN, APRN.

Completed
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT01275742: Completed NA study of Heart Failure, sponsored by Rebecca L. Dekker, PhD, RN, APRN.

NCT01275742 is a NA study of Heart Failure that has completed, run by Rebecca L. Dekker, PhD, RN, APRN. The registered enrollment target is 180 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01275742, a NA study of Heart Failure, has completed, sponsored by Rebecca L. Dekker, PhD, RN, APRN.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

Heart failure (HF) affects 5 million people in the US and is the most common cause of hospitalization in elderly adults. One-third of patients who are hospitalized with HF have major depression. Depressed HF patients have double the rates of morbidity and/or mortality and worse health-related quality of life than non-depressed HF patients. The investigators previous pilot research suggests that a brief Cognitive Therapy (CT) intervention may improve short-term cardiac survival among depressed hospitalized HF patients compared to non-depressed HF patients who received usual care. Therefore, the investigators will conduct a larger study to evaluate the effects of the intervention on longer cardiac event-free survival, symptoms of depression, health-related quality of life, and stress levels in patients with HF. The investigators hypothesize that patients in the intervention group will experience longer cardiac event-free survival, lower levels of depressive symptom, better health-related quality of life, and lower salivary cortisol levels at follow-up than patients who receive usual care.

Primary Outcome

To compare cardiac event-free survival at 3 months, 6 months, and up to five years between patients with HF and depressive symptoms who receive a brief cognitive therapy intervention (depressive symptom intervention group) and patients with HF and depressive symptoms who receive usual care (depressive symptom usual care group).

Conditions Studied

Interventions

  • BEHAVIORAL Brief Cognitive Therapy Intervention

Study Locations (1)

Kentucky

  • University of Kentucky Chandler Medical Center - Lexington

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2011-01
Est. Completion 2016-08
Phase NA
Rebecca L. Dekker, PhD, RN, APRN

1 total trials

What the finished NCT01275742 record still lists

NCT01275742 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Brief Cognitive Therapy Intervention is the first listed.

NCT01275742 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT01275742 about?

NCT01275742 is a clinical study titled "Helping Others Toward Positive Emotions in People With Heart Failure". Heart failure (HF) affects 5 million people in the US and is the most common cause of hospitalization in elderly adults. One-third of patients who are hospitalized with HF have major depression. Depressed HF patients have double the rates of morbidity and/or mortality and worse health-related qualit...

What is the current status of trial NCT01275742?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2011-01. Estimated completion is 2016-08.

What conditions does trial NCT01275742 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT01275742?

The interventions under investigation include: Brief Cognitive Therapy Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01275742?

This trial is sponsored by Rebecca L. Dekker, PhD, RN, APRN, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01275742 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01275742's enrollment target sits among peer trials

180 176th of 397 higher than 221 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01275742, the US trial registry maintained by the National Library of Medicine. NCT01275742 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.